Other common adverse reactions that occurred at a higher incidence among SAXENDA-treated patients included diarrhea, constipation, vomiting, dyspepsia, abdominal pain, dry mouth, gastritis, gastroesophageal reflux disease, flatulence, eructation and abdominal distension
Their safety, efficacy, and quality have not been verified through the FDA approval process
As the popularity of GLP-1 receptor agonists are being shown to benefit many chronic diseases over and above their effect on weight, John Deanfield, FRCP, FESC, professor of cardiology at the Institute of Cardiovascular Sciences at University College London, told Medical News Today
capsules) affect gyno risk